• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2013 年急性肾损伤：打破 AKI 生物标志物的障碍——终于取得进展。

Acute kidney injury in 2013: Breaking barriers for biomarkers in AKI--progress at last.

机构信息

University of California, San Diego Medicine 8342, UCSD Medical Center, 200 West Arbor Drive, San Diego, CA 92103, USA.

出版信息

Nat Rev Nephrol. 2014 Feb;10(2):74-6. doi: 10.1038/nrneph.2013.268. Epub 2013 Dec 24.

DOI:10.1038/nrneph.2013.268
PMID:24375051
Abstract

In 2013, four important papers were published that provide new insights on biomarkers in acute kidney injury (AKI). These studies demonstrate the potential for biomarkers to aid clinicians in improving the therapeutic management of patients with AKI and potentially improve patient outcomes.

摘要

2013 年，发表了四篇重要论文，为急性肾损伤（AKI）的生物标志物提供了新的见解。这些研究表明，生物标志物有可能帮助临床医生改善 AKI 患者的治疗管理，并有可能改善患者的预后。

相似文献

1
Acute kidney injury in 2013: Breaking barriers for biomarkers in AKI--progress at last.2013 年急性肾损伤：打破 AKI 生物标志物的障碍——终于取得进展。
Nat Rev Nephrol. 2014 Feb;10(2):74-6. doi: 10.1038/nrneph.2013.268. Epub 2013 Dec 24.
2
Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.生物标志物在急性肾损伤中的潜在应用：第十届急性透析质量倡议共识会议报告及建议摘要
Kidney Int. 2014 Mar;85(3):513-21. doi: 10.1038/ki.2013.374. Epub 2013 Oct 9.
3
Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers.
Nephrol Dial Transplant. 2017 Mar 1;32(3):419-422. doi: 10.1093/ndt/gfx023.
4
[Acute kidney injury].[急性肾损伤]
Dtsch Med Wochenschr. 2011 Feb;136(5):194-7. doi: 10.1055/s-0031-1272508. Epub 2011 Jan 26.
5
The assessment of acute kidney injury in critically ill patients.危重症患者急性肾损伤的评估。
Eur J Intern Med. 2017 Nov;45:54-58. doi: 10.1016/j.ejim.2017.09.041. Epub 2017 Oct 2.
6
A long journey for acute kidney injury biomarkers.急性肾损伤生物标志物的漫漫求索之路。
Ren Fail. 2020 Nov;42(1):154-165. doi: 10.1080/0886022X.2020.1721300.
7
[Acute kidney injury: progress in diagnosis and treatments. Topics: III. Approach to diagnosis; 2. Urinalysis and biomarker].[急性肾损伤：诊断与治疗进展。主题：三、诊断方法；2. 尿液分析与生物标志物]
Nihon Naika Gakkai Zasshi. 2014 May 10;103(5):1068-73. doi: 10.2169/naika.103.1068.
8
Biomarkers of acute kidney injury.急性肾损伤的生物标志物
Adv Chronic Kidney Dis. 2008 Jul;15(3):222-34. doi: 10.1053/j.ackd.2008.04.003.
9
Recent developments in the detection and management of acute kidney injury.急性肾损伤检测与管理的最新进展
Arch Dis Child. 2017 Jan;102(1):91-96. doi: 10.1136/archdischild-2015-309381. Epub 2016 Aug 5.
10
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement.急性疾病质量倡议共识会议关于急性肾损伤生物标志物的建议：共识声明。
JAMA Netw Open. 2020 Oct 1;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.

引用本文的文献

1
The association of post-lung transplant acute kidney injury with mortality is independent of primary graft dysfunction: A cohort study.肺移植后急性肾损伤与死亡率的相关性与原发性移植物功能障碍无关：一项队列研究。
Clin Transplant. 2019 Oct;33(10):e13678. doi: 10.1111/ctr.13678. Epub 2019 Aug 28.
2
Postreperfusion plasma endothelial activation markers are associated with acute kidney injury after lung transplantation.再灌注后血浆内皮激活标志物与肺移植后急性肾损伤相关。
Am J Transplant. 2019 Aug;19(8):2366-2373. doi: 10.1111/ajt.15402. Epub 2019 May 23.
3
Urinary neprilysin in the critically ill patient.

本文引用的文献

1
Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.生物标志物在急性肾损伤中的潜在应用：第十届急性透析质量倡议共识会议报告及建议摘要
Kidney Int. 2014 Mar;85(3):513-21. doi: 10.1038/ki.2013.374. Epub 2013 Oct 9.
2
Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children.肾绞痛指数的推导与验证，以改善对危重症儿童急性肾损伤的预测。
Kidney Int. 2014 Mar;85(3):659-67. doi: 10.1038/ki.2013.349. Epub 2013 Sep 18.
3
Acute kidney injury: Urine output in AKI--the canary in the coal mine?
危重症患者的尿中性肽链内切酶
BMC Nephrol. 2017 May 25;18(1):172. doi: 10.1186/s12882-017-0587-5.
4
Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies).围手术期及重症监护病房中的急性肾损伤（不包括肾脏替代治疗）。
Ann Intensive Care. 2016 Dec;6(1):48. doi: 10.1186/s13613-016-0145-5. Epub 2016 May 27.
5
DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections.尿液中的DDRGK1可指示重症监护病房中严重感染患者的肾小管细胞损伤。
J Nephropathol. 2016 Apr;5(2):65-71. doi: 10.15171/jnp.2016.13. Epub 2016 Mar 31.
6
Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment.少尿作为多发性骨髓瘤和肾功能损害患者死亡风险的早期指标。
Blood Res. 2015 Sep;50(3):167-72. doi: 10.5045/br.2015.50.3.167. Epub 2015 Sep 22.
急性肾损伤：急性肾损伤中的尿量——煤矿中的金丝雀？
Nat Rev Nephrol. 2013 Oct;9(10):568-70. doi: 10.1038/nrneph.2013.178. Epub 2013 Sep 10.
4
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.人类急性肾损伤中细胞周期阻滞生物标志物的发现与验证
Crit Care. 2013 Feb 6;17(1):R25. doi: 10.1186/cc12503.
5
Empirical relationships among oliguria, creatinine, mortality, and renal replacement therapy in the critically ill.危重症患者少尿、肌酐、死亡率和肾脏替代治疗之间的经验关系。
Intensive Care Med. 2013 Mar;39(3):414-9. doi: 10.1007/s00134-012-2767-x. Epub 2012 Dec 7.
6
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.使用肾单位损伤的尿生物标志物进行急诊科的诊断和预后分层：一项多中心前瞻性队列研究。
J Am Coll Cardiol. 2012 Jan 17;59(3):246-55. doi: 10.1016/j.jacc.2011.10.854.
7
Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury.上皮细胞在 G2/M 期的细胞周期停滞介导损伤后的肾脏纤维化。
Nat Med. 2010 May;16(5):535-43, 1p following 143. doi: 10.1038/nm.2144. Epub 2010 May 2.
8
Renal angina.肾绞痛。
Clin J Am Soc Nephrol. 2010 May;5(5):943-9. doi: 10.2215/CJN.07201009. Epub 2010 Mar 18.